136 related articles for article (PubMed ID: 36596317)
1. Investigating the physicochemical properties of solid dispersions based on semicrystalline carriers: A case study with ketoprofen.
Bertoni S; Albertini B; Passerini N
Int J Pharm; 2023 Feb; 632():122576. PubMed ID: 36596317
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
[TBL] [Abstract][Full Text] [Related]
4. Fast-dissolving and high-drug-loaded, Fatty Acid-based self-emulsifying solid dispersions of diacerein.
Aggarwal AK; Singh S
PDA J Pharm Sci Technol; 2012; 66(3):201-13. PubMed ID: 22634586
[TBL] [Abstract][Full Text] [Related]
5. Drug-Carrier Miscibility in Solid Dispersions of Glibenclamide and a Novel Approach to Enhance Its Solubility Using an Effervescent Agent.
Pisay M; Bhaskar KV; Mehta CH; Nayak UY; Koteshwara KB; Mutalik S
AAPS PharmSciTech; 2022 Oct; 23(8):284. PubMed ID: 36253571
[TBL] [Abstract][Full Text] [Related]
6. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
7. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
[TBL] [Abstract][Full Text] [Related]
8. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
9. Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers.
Chen Z; Liu Z; Qian F
Mol Pharm; 2015 Feb; 12(2):590-9. PubMed ID: 25569586
[TBL] [Abstract][Full Text] [Related]
10. Effect of different carriers on in vitro dissolution behavior and physicochemical characterization of glycyrrhetinic acid solid dispersions.
Qian J; Li F; Zhang C; Chai S; Liu T; Sui X
Pak J Pharm Sci; 2022 Nov; 35(6):1539-1548. PubMed ID: 36789813
[TBL] [Abstract][Full Text] [Related]
11. Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.
Swain RP; Subudhi BB
Drug Dev Ind Pharm; 2018 Jan; 44(1):56-65. PubMed ID: 28845687
[TBL] [Abstract][Full Text] [Related]
12. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
[TBL] [Abstract][Full Text] [Related]
13. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100.
Janssens S; De Zeure A; Paudel A; Van Humbeeck J; Rombaut P; Van den Mooter G
Pharm Res; 2010 May; 27(5):775-85. PubMed ID: 20195707
[TBL] [Abstract][Full Text] [Related]
14. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
Duong TV; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
[TBL] [Abstract][Full Text] [Related]
15. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
Altamimi MA; Neau SH
Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.
Liu C; Liu C; Desai KG
Drug Dev Ind Pharm; 2005 Jan; 31(1):1-10. PubMed ID: 15704852
[TBL] [Abstract][Full Text] [Related]
17. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
Friedrich H; Nada A; Bodmeier R
Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.
Ansari MT; Hussain A; Nadeem S; Majeed H; Saeed-Ul-Hassan S; Tariq I; Mahmood Q; Khan AK; Murtaza G
Biomed Res Int; 2015; 2015():109563. PubMed ID: 26097842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
